| Literature DB >> 23251789 |
S Mendis1, Igbal Al Bashir, Lanka Dissanayake, Cherian Varghese, Ibtihal Fadhil, Esha Marhe, Boureima Sambo, Firdosi Mehta, Hind Elsayad, Idrisa Sow, Maltie Algoe, Herbert Tennakoon, Lai Die Truong, Le Thi Tuyet Lan, Dismond Huiuinato, Neelamni Hewageegana, Naiema A W Fahal, Goitom Mebrhatu, Gado Tshering, Oleg Chestnov.
Abstract
Objective. The objective was to evaluate the capacity of primary care (PC) facilities to implement basic interventions for prevention and management of major noncommunicable diseases (NCDs), including cardiovascular diseases and diabetes. Methods. A cross-sectional survey was done in eight low- and middle-income countries (Benin, Bhutan, Eritrea, Sri Lanka, Sudan, Suriname, Syria, and Vietnam) in 90 PC facilities randomly selected. The survey included questions on the availability of human resources, equipment, infrastructure, medicines, utilization of services, financing, medical information, and referral systems. Results and Conclusions. Major deficits were identified in health financing, access to basic technologies and medicines, medical information systems, and the health workforce. The study has provided the foundation for strengthening PC to address noncommunicable diseases. There are important implications of the findings of this study for all low- and middle-income countries as capacity of PC is fundamental for equitable prevention and control of NCDs.Entities:
Year: 2012 PMID: 23251789 PMCID: PMC3517842 DOI: 10.1155/2012/584041
Source DB: PubMed Journal: Int J Hypertens Impact factor: 2.420
Characteristics of surveyed countries and primary care facilities, 2009/2011.
| Characteristics of primary care facilities | Participating countries | |||||||
|---|---|---|---|---|---|---|---|---|
| Benin | Eritrea | Sudan | Syria | Bhutan | Sri Lanka | Vietnam | Suriname | |
| World Bank income class* | Low income | Low income | Lower middle income | Lower middle income | Lower middle income | Lower middle income | Lower middle income | Upper middle income |
| Population served | 31333 | 64667 | 13083 | 34157 | 5071 | 35308 | 13267 | 13150 |
| Number of patients registered per month mean (SD) | 398 | 1190 | 847 | 1867 | 725 | 2343 | 238 | 1006 |
| Percentage of NCD patients registered per month | 4% | 11% | 30% | 11% | 11% | 24% | 62% | 69% |
| Total expenditure on health as % of gross domestic product** (2008) | 4.1 | 3.1 | 6.9 | 3.1 | 5.5 | 4.1 | 7.2 | 7.2 |
| Per capita total expenditure on health | 61 | 18 | 147 | 123 | 263 | 187 | 201 | 532 |
| Per capita government expenditure | 32 | 8 | 49 | 48 | 217 | 82 | 77 | 258 |
| Private expenditure on health as a % of total expenditure on health (2008) | 48.3 | 55.1 | 66.9 | 61.2 | 17.5 | 56.3 | 61.5 | 51.5 |
| Out-of-pocket expenditure as % | 99.9 | 100 | 91.9 | 100 | 100 | 83.3 | 91.7 | 44 |
*The World Bank. Country and Lending Groups by Income, http://data.worldbank.org/about/country-classifications/country-and-lending-groups.
**World Health Statistics 2011. Table 7, Health expenditure, http://www.who.int/whosis/whostat/2011/en/index.html.
Percentage availability of basic diagnostic tests in primary care facilities in defined areas in eight countries, 2009/2011.
| Urine and blood tests | Benin | Eritrea | Sudan | Syria | Bhutan | Sri Lanka | Vietnam | Suriname |
|---|---|---|---|---|---|---|---|---|
| Urine albumin | 100 | 67 | 92 | 64 | 100 | 46 | 0 | 70 |
| Urine glucose | 92 | 67 | 92 | 71 | 100 | 54 | 0 | 70 |
| Urine ketones | 42 | 33 | 58 | 79 | 0 | 0 | 0 | 40 |
| Blood glucose | 67 | 17 | 75 | 93 | 0 | 0 | 0 | 90 |
| Blood cholesterol | 25 | 0 | 33 | 14 | 0 | 8 | 0 | 20 |
| Serum creatinine | 33 | 0 | 58 | 0 | 0 | 8 | 0 | 10 |
| Serum troponin | 8 | 0 | 8 | 0 | 0 | 0 | 0 | 0 |
Percentage availability of selected essential medicines in primary care facilities in defined areas in eight countries, 2009/2011.
| Selected essential medicines | Benin | Eritrea | Sudan | Syria | Bhutan | Sri Lanka | Vietnam | Suriname |
|---|---|---|---|---|---|---|---|---|
| Atenolol | 8.3 | 0.0 | 42.9 | 14.3 | 0.0 | 69.2 | 93.3 | 100.0 |
| Enalapril | 33.3 | 0.0 | 28.6 | 14.3 | 0.0 | 69.2 | 60.0 | 30.0 |
| Amlodipine | 58.3 | 0.0 | 50.0 | 0.0 | 0.0 | 69.2 | 86.7 | 80.0 |
| Hydrochlorothiazide | 75.0 | 100.0 | 35.7 | 14.3 | 85.7 | 69.2 | 40.0 | 90.0 |
| Isosorbide dinitrate | 0.0 | 0.0 | 0.0 | 21.4 | 0.0 | 69.2 | 60.0 | 90.0 |
| Frusemide | 83.3 | 50.0 | 85.7 | 92.9 | 14.3 | 69.2 | 86.7 | 100.0 |
| Simvastatin or lovastatin | 8.3 | 0.0 | 35.7 | 7.1 | 0.0 | 23.1 | 46.7 | 50.0 |
| Insulin long acting | 0.0 | 0.0 | 21.4 | 21.4 | 0.0 | 30.8 | 0.0 | 80.0 |
| Insulin soluble | 0.0 | 0.0 | 28.6 | 21.4 | 0.0 | 30.8 | 0.0 | 80.0 |
| Metformin | 25.0 | 0.0 | 42.9 | 14.3 | 0.0 | 69.2 | 53.3 | 100.0 |
| Glibenclamide | 41.7 | 0.0 | 71.4 | 21.4 | 14.3 | 69.2 | 33.3 | 100.0 |
| Beclometasone inhaler | 33.3 | 16.7 | 21.4 | 28.6 | 0.0 | 15.4 | 6.7 | 80.0 |
| Prednisolone | 0.0 | 0.0 | 42.9 | 7.1 | 0.0 | 69.2 | 93.3 | 90.0 |
| Salbutamol inhaler | 33.3 | 100.0 | 71.4 | 78.6 | 0.0 | 30.8 | 20.0 | 90.0 |
| Salbutamol tablets | 66.7 | 100.0 | 85.7 | 14.3 | 100.0 | 69.2 | 93.3 | 90.0 |
| Ipratropium bromide | 0.0 | 0.0 | 14.3 | 14.3 | 0.0 | 30.8 | 0.0 | 20.0 |
| Aspirin | 100.0 | 100.0 | 100.0 | 21.4 | 0.0 | 69.2 | 100.0 | 100.0 |
| Paracetamol | 100.0 | 100.0 | 92.9 | 0.0 | 100.0 | 69.2 | 100.0 | 100.0 |
| Ibuprofen | 83.3 | 100.0 | 100.0 | 0.0 | 100.0 | 69.2 | 73.3 | 80.0 |
| Morphine (oral) | 0.0 | 0.0 | 14.3 | 0.0 | 0.0 | 15.4 | 0.0 | 20.0 |
| Morphine injection | 8.3 | 0.0 | 14.3 | 0.0 | 0.0 | 38.5 | 0.0 | 20.0 |
| Codeine | 8.3 | 0.0 | 35.7 | 0.0 | 0.0 | 15.4 | 33.3 | 60.0 |
| Glucose solution for injection | 91.7 | 0.0 | 0.0 | 0.0 | 57.1 | 53.8 | 66.7 | 80.0 |
| Sodium chloride infusion | 91.7 | 100.0 | 92.9 | 35.7 | 0.0 | 53.8 | 100.0 | 60.0 |
| Benzathine penicillin | 50.0 | 100.0 | 92.9 | 57.1 | 30.8 | 0.0 | 60.0 | 100.0 |
Financing of services and financing sources.
| Financing | Benin | Eritrea | Sudan | Syria | Bhutan | Sri Lanka | Vietnam | Suriname |
|---|---|---|---|---|---|---|---|---|
| Facilities providing consultations for free (%) | 42 | 100 | 50 | 100 | 100 | 69 | 27 | 100 |
| Subsidized by central or local government (%) | 0 | 100 | 50 | 100 | 100 | 69 | 20 | 100 |
| Subsidized by social health insurance (%) | 42 | 0 | 0 | 0 | 0 | 0 | 7 | 0 |
|
| ||||||||
| Facilities providing diagnostic tests for free (%) | 42 | 100 | 50 | 100 | 100 | 69 | 13 | 100 |
| Subsidized by central or local government (%) | 0 | 100 | 50 | 100 | 100 | 69 | 13 | 60 |
| Subsidized by social health insurance (%) | 42 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
|
| ||||||||
| Facilities providing medicines for free (%) | 42 | 100 | 50 | 100 | 100 | 62 | 0 | 70 |
| Subsidized by central or local government (%) | 0 | 100 | 50 | 100 | 100 | 62 | 0 | 60 |
| Subsidized by social health insurance (%) | 42 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |